XML 52 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Considerations (Details Textual)
9 Months Ended
Mar. 31, 2018
USD ($)
Fair Value Considerations (Textual)  
Contingent consideration, description The contingent consideration related to the AWH assets was prepaid up to the first $1.0 million in net revenue. Since we will not be able to manufacture more product (see Note 1), we are confident that our revenue for this product will not exceed $1.0 million and therefore, we have adjusted the remaining contingent consideration balance to zero.
Adjusted amount of contingent consideration for ProstaScint $ 25,000